Yu-an Xie

Guangxi Key Laboratory Of Reproductive Health And Birth Defects Prevention
Nanning, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Manganese modulates hepatocellular carcinoma cytotoxicity and doxorubicin sensitivity in a dose dependent manner.

Manganese modulates hepatocellular carcinoma cytotoxicity and doxorubicin sensitivity in a dose dependent manner.

Journal: Frontiers in oncology

Published: September 30, 2025

The role of GOT1 in cancer metabolism.

The role of GOT1 in cancer metabolism.

Journal: Frontiers in oncology

Published: October 29, 2024

A new biomarker to enhance the radiosensitivity of hepatocellular cancer: miRNAs.

A new biomarker to enhance the radiosensitivity of hepatocellular cancer: miRNAs.

Journal: Future oncology (London, England)

Published: August 15, 2022

MicroRNA-1271-5p inhibits cell proliferation and enhances radiosensitivity by targeting CDK1 in hepatocellular carcinoma.

MicroRNA-1271-5p inhibits cell proliferation and enhances radiosensitivity by targeting CDK1 in hepatocellular carcinoma.

Journal: Journal of biochemistry

Published: September 04, 2019

Y6, an Epigallocatechin Gallate Derivative, Reverses ABCG2-Mediated Mitoxantrone Resistance.

Y6, an Epigallocatechin Gallate Derivative, Reverses ABCG2-Mediated Mitoxantrone Resistance.

Journal: Frontiers in pharmacology

Published: September 05, 2018

The epigallocatechin gallate derivative Y6 reverses drug resistance mediated by the ABCB1 transporter both in vitro and in vivo.

The epigallocatechin gallate derivative Y6 reverses drug resistance mediated by the ABCB1 transporter both in vitro and in vivo.

Journal: Acta pharmaceutica Sinica. B

Published: June 21, 2018

MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.

MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.

Journal: The FEBS journal

Published: October 18, 2014

Epigallocatechin-3-gallate inhibits cell growth, induces apoptosis and causes S phase arrest in hepatocellular carcinoma by suppressing the AKT pathway.

Epigallocatechin-3-gallate inhibits cell growth, induces apoptosis and causes S phase arrest in hepatocellular carcinoma by suppressing the AKT pathway.

Journal: International journal of oncology

Published: November 14, 2013

A constructed HLA-A2-restricted pMAGE-A1(278-286) tetramer detects specific cytotoxic T lymphocytes in tumour tissues in situ.

A constructed HLA-A2-restricted pMAGE-A1(278-286) tetramer detects specific cytotoxic T lymphocytes in tumour tissues in situ.

Journal: The Journal of international medical research

Published: September 28, 2013

Two-stage model of chemically induced hepatocellular carcinoma in mouse.

Two-stage model of chemically induced hepatocellular carcinoma in mouse.

Journal: Oncology research

Published: September 26, 2013

Management of intractable epistaxis in patients who received radiation therapy for nasopharyngeal carcinoma.

Management of intractable epistaxis in patients who received radiation therapy for nasopharyngeal carcinoma.

Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Published: November 27, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026